Catalyst Wire Dossier Catalyst Wire Dossier

Imiquimod 5%

Imiquimod 5%
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Imiquimod 5%, covering 2020-02-05 to 2020-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study [Phase 3]

See pricing